Gentherm is trading 7.14% down at $26.41 after third-quarter adjusted EPS of $0.33 missed the $0.65 analyst estimate.
- Revenue of $405.1 million slightly beat forecasts, while Modine-related integration costs also contributed to the decline.
- Management raised 2026 revenue guidance, largely reflecting Modineβs contribution; higher costs and margin pressure weighed on profitability.
- The broader market and industrials were also lower, but the earnings miss is the clearest company-specific explanation for the move.